Literature DB >> 21788557

Ongoing challenge of stage II colon cancer.

Neal J Meropol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21788557     DOI： 10.1200/JCO.2011.35.4571

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

1.  Hospital academic status and value of care for nonmetastatic colon cancer.

Authors:  Christine M Veenstra; Andrew J Epstein; Kaijun Liao; Jennifer J Griggs; Craig E Pollack; Katrina Armstrong
Journal:  J Oncol Pract       Date:  2015-04-21       Impact factor: 3.840

2.  Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.

Authors:  Leigh Casadaban; Garth Rauscher; Mebea Aklilu; Dana Villenes; Sally Freels; Ajay V Maker
Journal:  Cancer       Date:  2016-07-15       Impact factor: 6.860

3.  Current status of gene expression profiling to assist decision making in stage II colon cancer.

Authors:  Cheng E Chee; Neal J Meropol
Journal:  Oncologist       Date:  2014-05-28

4.  CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.

Authors:  Piero Dalerba; Debashis Sahoo; Soonmyung Paik; Xiangqian Guo; Greg Yothers; Nan Song; Nate Wilcox-Fogel; Erna Forgó; Pradeep S Rajendran; Stephen P Miranda; Shigeo Hisamori; Jacqueline Hutchison; Tomer Kalisky; Dalong Qian; Norman Wolmark; George A Fisher; Matt van de Rijn; Michael F Clarke
Journal:  N Engl J Med       Date:  2016-01-21       Impact factor: 91.245

5.  Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.

Authors:  Aslam Ejaz; Leigh Casadaban; Ajay V Maker
Journal:  J Surg Res       Date:  2017-03-31       Impact factor: 2.192

6.  CDX2 Biomarker Testing and Adjuvant Therapy for Stage II Colon Cancer: An Exploratory Cost-Effectiveness Analysis.

Authors:  Fernando Alarid-Escudero; Deborah Schrag; Karen M Kuntz
Journal:  Value Health       Date:  2021-11-02       Impact factor: 5.725

7.  Aquaporin 1 expression is associated with response to adjuvant chemotherapy in stage II and III colorectal cancer.

Authors:  Hideko Imaizumi; Keiichiro Ishibashi; Seiichi Takenoshita; Hideyuki Ishida
Journal:  Oncol Lett       Date:  2018-03-05       Impact factor: 2.967

8.  Cost profiles of colorectal cancer patients in Italy based on individual patterns of care.

Authors:  Silvia Francisci; Stefano Guzzinati; Maura Mezzetti; Emanuele Crocetti; Francesco Giusti; Guido Miccinesi; Eugenio Paci; Catia Angiolini; Anna Gigli
Journal:  BMC Cancer       Date:  2013-07-05       Impact factor: 4.430

9.  A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.

Authors:  Wenyuan Zhao; Beibei Chen; Xin Guo; Ruiping Wang; Zhiqiang Chang; Yu Dong; Kai Song; Wen Wang; Lishuang Qi; Yunyan Gu; Chenguang Wang; Da Yang; Zheng Guo
Journal:  Oncotarget       Date:  2016-04-05

10.  Prognostic value of high-expression of miR-17-92 cluster in various tumors: evidence from a meta-analysis.

Authors:  Kaiping Zhang; Li Zhang; Meng Zhang; Yin Zhang; Dengxin Fan; Jiabin Jiang; Liqin Ye; Xiang Fang; Xianguo Chen; Song Fan; Min Chao; Chaozhao Liang
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.